Raul Insa Boronat

3PUBLICATIONS
13CO-AUTHORS
Gene and molecular therapyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 09, 2022
A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease.

Josep Gamez, Matilde Calopa, Esteban Muñoz

|May 24, 2019
Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study.

Josep Gamez, María Salvadó, Núria Reig

Pageof 1